SCHEMBL8971047

SCHEMBL8971047

Cc1ccccc1OC(CCNN)c1ccccc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 12/20 0.76
SLC6A2 P23975 11/20 0.76
CYP1A2 P05177 4/20 0.76
CYP3A4 P08684 4/20 0.76
CYP2D6 P10635 4/20 0.76
TSHR P16473 3/20 0.76
SLC6A3 Q01959 3/20 0.76
CHRM1 P11229 2/20 0.76
ADRA2B P18089 2/20 0.76
HTR2A P28223 2/20 0.76
HTR2C P28335 2/20 0.76
HRH1 P35367 2/20 0.76
OPRM1 P35372 2/20 0.76
DRD3 P35462 2/20 0.76
OPRK1 P41145 2/20 0.76
HTR2B P41595 2/20 0.76
KCNH2 Q12809 2/20 0.76
KLF10 Q13118 2/20 0.76
HRH3 Q9Y5N1 2/20 0.76
KMT2A Q03164 2/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Atomoxetine SCHEMBL34268 0.86 SLC6A4 (1.00) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6
Atomoxetine SCHEMBL12047445 0.86 SLC6A4 (1.00) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6
Atomoxetine SCHEMBL2209541 0.86 SLC6A4 (1.00) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6
Atomoxetine SCHEMBL29440242 0.86 SLC6A4 (1.00) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6
Atomoxetine SCHEMBL5783906 0.86 SLC6A4 (1.00) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6
Atomoxetine SCHEMBL341802 0.86 SLC6A4 (1.00) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6
Atomoxetine SCHEMBL649168 0.85 SLC6A2 (1.00) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6
Atomoxetine SCHEMBL2206798 0.85 SLC6A2 (1.00) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6
Atomoxetine SCHEMBL1560986 0.85 SLC6A2 (1.00) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6
Atomoxetine SCHEMBL29528186 0.85 SLC6A2 (1.00) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0545425-B1 2-(3-Phenylpropyl)hydrazines, intermediates in and a process for the preparation thereof, and their use as medicaments HOECHST ROUSSEL PHARMA (US) 1996-03-20 EP disclosed
US-5268468-A Or optical isomers thereof HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1993-12-07 US disclosed
US-5229417-A Obsessive compulsive disorders HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1993-07-20 US disclosed
EP-0545425-A1 2-(3-Phenylpropyl)hydrazines, intermediates in and a process for the preparation thereof, and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1993-06-09 EP disclosed